Characterization of early pathogenesis in the SOD1G93A mouse model of ALS: Part II, results and discussion

Brain and Behavior

Volumn 3, Issue 4, 2013, Pages 431-457

  Vinsant, Sharon ^a   Mansfield, Carol ^a   Jimenez Moreno, Ramon ^a   Moore, Victoria Del Gaizo ^b   Yoshikawa, Masaaki ^a,d   Hampton, Thomas G ^c   Prevette, David ^a   Caress, James ^a   Oppenheim, Ronald W ^a   Milligan, Carol ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b ELON UNIVERSITY   (United States)

^c Mouse Specifics Inc   (United States)

^d NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Axons; Cytoplasmic vacuoles; Glia; Mega mitochondria; Mitochondria; Motoneurons; Motor function; NMJs

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; MEMBRANE PROTEIN; PROTEIN P14; PROTEIN P30; PROTEIN P60; PROTEIN P7; PROTEIN P75; UNCLASSIFIED DRUG;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATROPHY; AUTONOMIC INNERVATION; CELL LOSS; CELL TRANSPORT; CELL ULTRASTRUCTURE; CELL VACUOLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; GAIT DISORDER; GLIA CELL; MOLECULAR DYNAMICS; MUSCLE DENERVATION; MUSCLE WEAKNESS; NERVE DEGENERATION; NERVE ENDING; NERVE FIBER; NEUROMUSCULAR SYNAPSE; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD VENTRAL HORN; VENTRAL ROOT;

EID: 84893493940     PISSN: None     EISSN: 21623279     Source Type: Journal    
DOI: 10.1002/brb3.142     Document Type: Article

References (132)

1. Aggarwal, A., and G. Nicholson. 2002. Detection of preclinical motor neurone loss in SOD1 mutation carriers using motor unit number estimation. J. Neurol. Neursurg. Psych. 73:199-201.
2. Amende, I., A. Kale, S. McCue, S. Glazier, J. P. Morgan, and T. G. Hampton. 2005. Gait dynamics in mouse models of Parkinson's disease and Huntington's disease. J. Neuroeng. Rehabil. 2:20.
3. Amendola, J., J. P. Gueritaud, B. L. d'Incamps, C. Bories, S. Liabeuf, C. Allene, et al. 2007. Postnatal electrical and morphological abnormalities in lumbar motoneurons from transgenic mouse models of amyotrophic lateral sclerosis. Arch. Ital. Biol. 145:311-323.
4. Andrews, J. M., and M. B. Gardner. 1974. Lower motor neuron degeneration associated with type C RNA virus infection in mice: neuropathological features. J. Neuropathol. Exp. Neurol. 33:285-307.
5. Barbeito, L. H., M. Pehar, P. Cassina, M. R. Vargas, H. Peluffo, L. Viera, et al. 2004. A role for astrocytes in motor neuron loss in amyotrophic lateral sclerosis. Brain Res. Brain Res. Rev. 47:263-274.
6. Bendotti, C., N. Calvaresi, L. Chiveri, A. Prelle, M. Moggio, M. Braga, et al. 2001. Early vacuolization and mitochondrial damage in motor neurons of FALS mice are not associated with apoptosis or with changes in cytochrome oxidase histochemical reactivity. J. Neurol. Sci. 191:25-33.
7. Bettini, N. L., T. S. Moores, B. Baxter, J. Deuchars, and S. H. Parson. 2007. Dynamic remodelling of synapses can occur in the absence of the parent cell body. BMC Neurosci. 8:79.
8. Bilsland, L. G., E. Sahai, G. Kelly, M. Golding, L. Greensmith, and G. Schiavo. 2010. Deficits in axonal transport precede ALS symptoms in vivo. Proc. Natl. Acad. Sci. USA 107:20523-20528.
9. Blijham, P. J., H. J. Schelhaas, H. J. Ter Laak, B. G. van Engelen, and M. J. Zwarts. 2007. Early diagnosis of ALS: the search for signs of denervation in clinically normal muscles. J. Neurol. Sci. 263:154-157.
10. Bodian, D. 1964. An electron-microscopic study of the monkey spinal cord. I. Fine structure of normal motor column. II. Effects of retrograde chromatolysis. III. Cytologic effects of mild and virulent poliovirus infection. Bull. Johns Hopkins Hosp. 114:13-119.
11. Boillée, S., C. Vande Velde, and D. W. Cleveland. 2006. ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 52:39-59.
12. Brunet, N., O. Tarabal, M. Portero-Otín, R. W. Oppenheim, J. E. Esquerda, and J. Calderó. 2007. Survival and death of mature avian motoneurons in organotypic slice culture: trophic requirements for survival and different types of degeneration. J. Comp. Neurol. 501:669-690.
13. Brunet, N., O. Tarabal, J. E. Esquerda, and J. Calderó. 2009. Excitotoxic motoneuron degeneration induced by glutamate receptor agonists and mitochondrial toxins in organotypic cultures of chick embryo spinal cord. J. Comp. Neurol. 516:277-290.
14. Chakkalakal, J. V., S. Kuang, M. Buffelli, J. W. Lichtman, and J. R. Sanes. 2012. Mouse transgenic lines that selectively label type I, type IIA and types IIX+B skeletal muscle fibers. Genesis 50:50-58.
15. Chang, L. W., and H. A. Hartmann. 1972. Electron microscopic histochemical study on the localization and distribution of mercury in the nervous system after mercury intoxication. Exp. Neurol. 35:122-137.
16. Chiesa, R., P. Piccardo, S. Dossena, L. Nowoslawski, K. A. Roth, and Ghetti. 2005. Bax deletion prevents neuronal loss but not neurological symptoms in a transgenic model of inherited prion disease. Proc. Natl. Acad. Sci. USA 102:238-243.
17. Chiu, A. Y., P. Zhai, M. C. Dal Canto, T. M. Peters, Y. W. Kwon, S. M. Prattis, et al. 1995. Age-dependent penetrance of disease in a transgenic mouse model of familial amyotrophic lateral sclerosis. Mol. Cell. Neurosci. 6:349-362.
18. Clarke, P. G., and R. W. Oppenheim. 1995. Neuron death in vertebrate development: in vivo methods. Methods Cell Biol. 46:277-321.
19. Coleman, M. P., and V. H. Perry. 2002. Axon pathology in neurological disease: a neglected therapeutic target. Trends Neurosci. 25:532-537.
20. Conforti, L., R. Adalbert, and M. P. Coleman. 2007. Neuronal death: where does the end begin? Trends Neurosci. 30:159-166.
21. Conradi, S., and S. Skoglund. 1969. Observations on the ultrastructure of the initial motor axon segment and dorsal root boutons on the motoneurons in the lumbosacral spinal cord of the cat during postnatal development. Acta Physiol. Scand. Suppl. 333:53-76.
22. Domeniconi, M., B. L. Hempstead, and M. V. Chao. 2007. Pro-NGF secreted by astrocytes promotes motor neuron cell death. Mol. Cell. Neurosci. 34:271-279.
23. Eisen, A. 1995. Amyotrophic lateral sclerosis. Intern. Med. 34:824-832.
24. Fan, J., Z. Hu, L. Zeng, W. Lu, X. Tang, J. Zhang, et al. 2008. Golgi apparatus and neurodegenerative diseases. Int. J. Dev. Neurosci. 26:523-534.
25. Ferri, A., J. R. Sanes, M. P. Coleman, J. M. Cunningham, and A. C. Kato. 2003. Inhibiting axon degeneration and synapse loss attenuates apoptosis and disease progression in a mouse model of motoneuron disease. Curr. Biol. 13:669-673.
26. Fischer, L. R., D. G. Culver, P. Tennant, A. A. Davis, M. Wang, A. Castellano-Sanchez, et al. 2004. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp. Neurol. 185:232-240.
27. Frank, E. 2009. A new class of spinal interneurons: the origin and function of C boutons is solved. Neuron 64:593-595.
28. Frey, D., C. Schneider, L. Xu, J. Borg, W. Spooren, and P. Caroni. 2000. Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. J. Neurosci. 20:2534-2542.
29. Gardner, M. B., B. E. Henderson, J. E. Officer, R. W. Rongey, J. C. Parker, C. Oliver, et al. 1973. A spontaneous lower motor neuron disease apparently caused by indigenous type-C RNA virus in wild mice. J. Natl. Cancer Inst. 51:1243-1254.
30. Gerber, Y. N., J. C. Sabourin, M. Rabano, M. D. Vivanco, and F. E. Perrin. 2012. Early functional deficit and microglial disturbances in a mouse model of amyotrophic lateral sclerosis. PLoS ONE 7:e36000. doi: 10.1371/journal.pone.0036000.
31. Gifondorwa, D. J., M. B. Robinson, C. D. Hayes, A. R. Taylor, D. M. Prevette, R. W. Oppenheim, et al. 2007. Exogenous delivery of heat shock protein 70 increases lifespan in a mouse model of amyotrophic lateral sclerosis. J. Neurosci. 27:13173-13180.
32. Gifondorwa, D. J., R. Jimenz-Moreno, C. D. Hayes, H. Rouhani, M. B. Robinson, J. L. Strupe, et al. 2012. Administration of recombinant heat shock protein 70 delays peripheral muscle denervation in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Neurol. Res. Int. 2012:170426. doi: 10.1155/2012/170426.
33. Gonatas, N. K., A. Stieber, Z. Mourelatos, Y. Chen, J. O. Gonatas, S. H. Appel, et al. 1992. Fragmentation of the Golgi apparatus of motor neurons in amyotrophic lateral sclerosis. Am. J. Pathol. 140:731-737.
34. Gonatas, N. K., A. Stieber, and J. O. Gonatas. 2006. Fragmentation of the Golgi apparatus in neurodegenerative diseases and cell death. J. Neurol. Sci. 246:21-30.
35. Gould, T. W., and R. W. Oppenheim. 2007. Synaptic dysfunction in disease and following injury in the developing and adult nervous system: caveats in the choice of therapeutic intervention. Neurosci. Biobehav. Rev. 31:1073-1087.
36. Gould, T. W., R. R. Buss, S. Vinsant, D. Prevette, W. Sun, C. M. Knudson, et al. 2006. Complete dissociation of motor neuron death from motor dysfunction by Bax deletion in a mouse model of ALS. J. Neurosci. 26:8774-8786.
37. Gurney, M. E., H. Pu, A. Y. Chiu, M. C. Dal Canto, C. Y. Polchow, D. D. Alexander, et al. 1994. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 264:1772-1775.
38. Hafezparast, M., R. Klocke, C. Ruhrberg, A. Marquardt, A. Ahmad-Annuar, S. Bowen, et al. 2003. Mutations in dynein link motor neuron degeneration to defects in retrograde transport. Science 300:808-810.
39. Hall, E. D., J. A. Oostveen, and M. E. Gurney. 1998. Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS. Glia 23:249-256.
40. G93A mouse model of amyotrophic lateral sclerosis. Neurobiol. Dis. 28:154-164.
41. Henkel, J. S., D. R. Beers, W. Zhao, and S. H. Appel. 2009. Microglia in ALS: the good, the bad, and the resting. J. Neuroimmune Pharmacol. 4:389-398.
42. G93A causes mitochondrial vacuolation by expansion of the intermembrane space and by involvement of SOD1 aggregation and peroxisomes. BMC Neurosci. 4:16.
43. Ilieva, E. V., V. Ayala, M. Jové, E. Dalfó, D. Cacabelos, M. Povedano, et al. 2007. Oxidative and endoplasmic reticulum stress interplay in sporadic amyotrophic lateral sclerosis. Brain 130:3111-3123.
44. Ilieva, H. S., K. Yamanaka, S. Malkmus, O. Kakinohana, T. Yaksh, M. Marsala, et al. 2008. Mutant dynein (Loa) triggers proprioceptive axon loss that extends survival only in the SOD1 ALS model with highest motor neuron death. Proc. Natl. Acad. Sci. USA 105:12599-12604.
45. Ilieva, H., M. Polymenidou, and D. W. Cleveland. 2009. Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J. Cell Biol. 187:761-772.
46. Jaarsma, D., E. D. Haasdijk, J. A. Grashorn, R. Hawkins, W. van Duijn, H. W. Verspaget, et al. 2000. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1. Neurobiol. Dis. 7(6 Pt B):623-643.
47. Jaarsma, D., F. Rognoni, W. van Duijn, H. W. Verspaget, E. D. Haasdijk, and J. C. Holstege. 2001. CuZn superoxide dismutase (SOD1) accumulates in vacuolated mitochondria in transgenic mice expressing amyotrophic lateral sclerosis-linked SOD1 mutations. Acta Neuropathol. 102:293-305.
48. Jablonka, S., S. Wiese, and M. Sendtner. 2004. Axonal defects in mouse models of motoneuron disease. J. Neurobiol. 58:272-286.
49. Jang, Y. C., M. S. Lustgarten, Y. Liu, F. L. Muller, A. Bhattacharya, H. Liang, et al. 2010. Increased superoxide in vivo accelerates age-associated muscle atrophy through mitochondrial dysfunction and neuromuscular junction degeneration. FASEB J. 24:1376-1390.
50. Jiang, M., J. E. Schuster, R. Fu, T. Siddique, and C. J. Heckman. 2009. Progressive changes in synaptic inputs to motoneurons in adult sacral spinal cord of a mouse model of amyotrophic lateral sclerosis. J. Neurosci. 29:15031-15038.
51. Johnston, I. P., and T. A. Sears. 1989. Ultrastructure of axotomized alpha and gamma motoneurons in the cat thoracic spinal cord. Neuropathol. Appl. Neurobiol. 15:149-163.
52. Jullien, J. P. 2007. ALS: astrocytes move in as deadly neighbors. Nat. Neurosci. 10:535-537.
53. Kanekura, K., H. Suzuki, S. Aiso, and M. Matsuoka. 2009. ER stress and unfolded protein response in amyotrophic lateral sclerosis. Mol. Neurobiol. 39:81-89.
54. Kang, S. H., M. Fukaya, J. K. Yang, J. D. Rothstein, and D. E. Bergles. 2010. NG2+ CNS glial progenitors remain committed to the oligodendrocyte lineage in postnatal life and following neurodegeneration. Neuron 68:668-681.
55. Kieran, D., M. Hafezparast, S. Bohnert, J. R. T. Dick, J. Martin, G. Schiavo, et al. 2005. A mutation in dynein rescues axonal transport defects and extends the life span of ALS mice. J. Cell Biol. 169:561-567.
56. King, A. E., T. C. Dickson, C. A. Blizzard, A. Woodhouse, S. S. Foster, R. S. Chung, et al. 2011. Neuron-glia interactions underlie ALS-like axonal cytoskeletal pathology. Neurobiol. Aging 32:459-469.
57. Kong, J., and Z. Xu. 1998. Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1. J. Neurosci. 18:3241-3250.
58. Kostic, V., V. Jackson-Lewis, F. de Bilbao, M. Dubois-Dauphin, and S. Przedborski. 1997. Bcl-2: prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis. Science 277:559-562.
59. Lee, Y. I., M. Mikesh, I. Smith, M. Rimer, and W. Thompson. 2011. Muscles in a mouse model of spinal muscular atrophy show profound defects in neuromuscular development even in the absence of failure in neuromuscular transmission or loss of motor neurons. Dev. Biol. 356:432-444.
60. Li, W., P. A. Ochalski, S. Brimijoin, L. M. Jordan, and J. I. Nagy. 1995. C-terminals on motoneurons: electron microscope localization of cholinergic markers in adult rats and antibody-induced depletion in neonates. Neuroscience 65:879-891.
61. Li, H., Y. Chen, A. F. Jones, R. H. Sanger, L. P. Collis, R. Flannery, et al. 2008. Bcl-xL induces Drp1-dependent synapse formation in cultured hippocampal neurons. Proc. Natl. Acad. Sci. USA 105:2169-2174.
62. Libby, R. T., Y. Li, O. V. Savinova, J. Barter, R. S. Smith, R. W. Nickells, et al. 2005. Susceptibility to neurodegeneration in a glaucoma is modified by Bax gene dosage. PLoS Genet. 1:17-26.
63. Ligon, L. A., B. H. LaMonte, K. E. Wallace, N. Weber, R. G. Kalb, and E. L. Holzbaur. 2005. Mutant superoxide dismutase disrupts cytoplasmic dynein in motor neurons. Neuroreport. 16:533-536.
64. Lin, Y. C., and A. J. Koleske. 2010. Mechanisms of synapse and dendrite maintenance and their disruption in psychiatric and neurodegenerative disorders. Annu. Rev. Neurosci. 33:349-378.
65. Locke, M., E. G. Noble, and B. G. Atkinson. 1991. Inducible isoform of HSP70 is constitutively expressed in a muscle fiber type specific pattern. Am. J. Physiol. 261:C774-C779.
66. Locke, M., B. G. Atkinson, R. M. Tanguay, and E. G. Noble. 1994. Shifts in type I fiber proportion in rat hindlimb muscle are accompanied by changes in HSP72 content. Am. J. Physiol. 266:C1240-C1246.
67. MacAskill, A. F., T. A. Atkin, and J. T. Kittler. 2010. Mitochondrial trafficking and the provision of energy and calcium buffering at excitatory synapses. Eur. J. Neurosci. 32:231-240.
68. Magrané, J., and G. Manfredi. 2009. Mitochondrial function, morphology, and axonal transport in amyotrophic lateral sclerosis. Antioxid. Redox Signal. 11:1615-1626.
69. Mancuso, R., S. Oliván, R. Osta, and X. Navarro. 2011. Evolution of gait abnormalities in SOD1(G93A) transgenic mice. Brain Res. 1406:65-73. doi: 10.1016/j.brainres.2011.06.033.
70. Manfredi, G., and Z. Xu. 2005. Mitochondrial dysfunction and its role in motor neuron degeneration in ALS. Mitochondrion 5:77-87.
71. Marinkovic, P., M. S. Reuter, M. S. Brill, L. Godinho, M. Kerschensteiner, and T. Misgeld. 2012. Axonal transport deficits and degeneration can evolve independently in mouse models of amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA 109:4296-4301.
72. Martin, L. J. 2010. Mitochondrial and cell death mechanisms in neurodegenerative diseases. Pharmaceuticals (Basel) 3:839-915.
73. Martin, L. J., and Q. Chang. 2012. Inhibitory synaptic regulation of motoneurons: a new target of disease mechanisms in amyotrophic lateral sclerosis. Mol. Neurobiol. 45:30-42.
74. Martinez-Menárguez, J. A., R. Prekeris, V. M. Oorschot, R. Scheller, J. W. Slot, H. J. Geuze, et al. 2001. Peri-Golgi vesicles contain retrograde but not anterograde proteins consistent with the cisternal progression model of intra-Golgi transport. J. Cell Biol. 155:1213-1224.
75. McGeer, P. L., T. Kawamata, D. G. Walker, H. Akiyama, I. Tooyama, and E. G. McGeer. 1993. Microglia in degenerative neurological disease. Glia 7:84-92.
76. Mead, R. J., E. J. Bennett, A. J. Kennerley, P. Sharp, C. Sunyach, P. Kasher, et al. 2011. Optimised and rapid pre-clinical screening in the SOD1(G93A) transgenic mouse model of amyotrophic lateral sclerosis (ALS). PLoS ONE 6:e23244. doi: 10.1371/journal.pone.0023244.
77. Medana, I. M., and M. M. Esiri. 2003. Axonal damage: a key predictor of outcome in human CNS diseases. Brain 126:515-530.
78. Mentis, G. Z., D. Blivis, W. Liu, E. Drobac, M. E. Crowder, L. Kong, et al. 2011. Early functional impairment of sensory-motor connectivity in a mouse model of spinal muscular atrophy. Neuron 69:453-467.
79. Monk, P. N., and P. J. Shaw. 2006. ALS: life and death in a bad neighborhood. Nat. Med. 12:885-887.
80. Morfini, G. A., M. Burns, L. I. Binder, N. M. Kanaan, N. LaPointe, D. A. Bosco, et al. 2009. Axonal transport defects in neurodegenerative diseases. J. Neurosci. 29:12776-12786.
81. Mourelatos, Z., N. K. Gonatas, A. Stieber, M. E. Gurney, and M. C. Dal Canto. 1996. The Golgi apparatus of spinal cord motor neurons in transgenic mice expressing mutant Cu, Zn superoxide dismutase becomes fragmented in early, preclinical stages. Proc. Natl. Acad. Sci. USA 93:5472-5477.
82. Murakami, T., M. Nagai, K. Miyazaki, N. Morimoto, Y. Ohta, T. Kurata, et al. 2007. Early decrease of mitochondrial DNA repair enzymes in spinal motor neurons of presymptomatic transgenic mice carrying a mutant SOD1 gene. Brain Res. 1150:182-189.
83. Nagai, M., D. B. Re, T. Nagata, A. Chalazonitis, T. M. Jessell, H. Wichterle, et al. 2007. Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat. Neurosci. 10:615-622.
84. Nagata, T., H. Ilieva, T. Murakami, M. Shiote, H. Narai, Y. Ohta, et al. 2007. Increased ER stress during motor neuron degeneration in a transgenic mouse model of amyotrophic lateral sclerosis. Neurol. Res. 29:767-771.
85. Nagy, J. I., T. Yamamoto, and L. M. Jordan. 1993. Evidence for the cholinergic nature of C-terminals associated with subsurface cisterns in alpha-motoneurons of rat. Synapse 15:17-32.
86. Nishitoh, H., H. Kadowaki, A. Nagai, T. Maruyama, T. Yokota, H. Fukutomi, et al. 2008. ALS-linked mutant SOD1 induces ER stress- and ASK1-dependent motor neuron death by targeting Derlin-1. Genes Dev. 22:1451-1464.
87. Oppenheim, R. W., C. Milligan, and C. von Bartheld. 2013. Programmed cell death and neurotrophic factors. Pp. 405-435 in L. Squire, D. Berg, F. E. Bloom, S. duLac, A. Ghosh, and N. C. Spitzer, eds. Fundamental neuroscience. 4th ed. Academic Press, San Diego, CA.
88. G93A transgenic ALS mice. J. Neurosci. 31:4166-4177.
89. Palop, J. J., J. Chin, and L. Mucke. 2006. A network dysfunction perspective on neurodegenerative diseases. Nature 443:768-773.
90. G93A(Low) mice. J. Neurophysiol. 102:3627-3642.
91. Pehar, M., P. Cassina, M. R. Vargas, R. Castellanos, L. Viera, J. S. Beckman, et al. 2004. Astrocytic production of nerve growth factor in motor neuron apoptosis: implications for amyotrophic lateral sclerosis. J. Neurochem. 89:464-473.
92. Pehar, M., M. R. Vargas, P. Cassina, A. G. Barbeito, J. S. Beckman, and L. Barbeito. 2005. Complexity of astrocyte-motor neuron interactions in amyotrophic lateral sclerosis. Neurodegener. Dis. 2:139-146.
93. Perlson, E., G. B. Jeong, J. L. Ross, R. Dixit, K. E. Wallace, R. G. Kalb, et al. 2009. A switch in retrograde signaling from survival to stress in rapid-onset neurodegeneration. J. Neurosci. 29:9903-9917.
94. Pullen, A. H., and D. Athanasiou. 2009. Increase in presynaptic territory of C-terminals on lumbar motoneurons of G93A SOD1 mice during disease progression. Eur. J. Neurosci. 29:551-561.
95. Pun, S., A. F. Santos, S. Saxena, L. Xu, and P. Caroni. 2006. Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF. Nat. Neurosci. 9:408-419.
96. Raff, M. C., A. V. Whitmore, and J. T. Finn. 2002. Axonal self-destruction and neurodegeneration. Science 296:868-871.
97. Rao, M. V., and R. A. Nixon. 2003. Defective neurofilament transport in mouse models of amyotrophic lateral sclerosis: a review. Neurochem. Res. 28:1041-1047.
98. Rintoul, G. L., and I. J. Reynolds. 2009. Mitochondrial trafficking and morphology in neuronal injury. Biochim. Biophys. Acta 1802:143-150.
99. Robinson, M. B., D. J. Gifondorwa, and C. Milligan. 2011. Mechanisms of the motoneuron stress response and its relevance in neurodegeneration. Pp. 45-62 in A. S. McNeill, ed. Neurodegeneration: theory, disorders and treatments. Nova Science Publishers, Inc., Hauppauge, NY.
100. Rossi, D., L. Brambilla, C. F. Valori, C. Roncoroni, A. Crugnola, T. Yokota, et al. 2008. Focal degeneration of astrocytes in amyotrophic lateral sclerosis. Cell Death Differ. 15:1691-1700.
101. Rothstein, J. D. 1995. Excitotoxic mechanisms in the pathogenesis of amyotrophic lateral sclerosis. Adv. Neurol. 68:7-20; discussion 21-27.
102. Rothstein, J. D., R. Kuncl, V. Chaudhry, L. Clawson, D. R. Cornblath, J. T. Coyle, et al. 1991. Excitatory amino acids in amyotrophic lateral sclerosis: an update. Ann. Neurol. 30:224-225.
103. Roy, R. R., K. M. Baldwin, and V. R. Edgerton. 1991. The plasticity of skeletal muscle: effects of neuromuscular activity. Exerc. Sport Sci. Rev. 19:269-312.
104. Sagot, Y., M. Dubois-Dauphin, S. A. Tan, F. de Bibao, P. Aebischer, J.-C. Martinou, et al. 1995. Bcl-2 overexpression prevents motoneuron cell body loss but not axonal degeneration in a mouse model of neurodegenerative disease. J. Neurosci. 15:7727-7733.
105. Sargsyan, S. A., P. N. Monk, and P. J. Shaw. 2005. Microglia as potential contributors to motor neuron injury in amyotrophic lateral sclerosis. Glia 51:241-253.
106. Sasaki, S., H. Warita, K. Abe, and M. Iwata. 2004. Slow component of axonal transport is impaired in the proximal axon of transgenic mice with a G93A mutant SOD1 gene. Acta Neuropathol. 107:452-460.
107. Sau, D., P. Rusmini, V. Crippa, E. Onesto, E. Bolzoni, A. Ratti, et al. 2011. Dysregulation of axonal transport and motorneuron diseases. Biol. Cell 103:87-107.
108. Saxena, S., and P. Caroni. 2007. Mechanisms of axon degeneration: from development to disease. Prog. Neurobiol. 83:174-191.
109. Saxena, S., E. Cabuy, and P. Caroni. 2009. A role for motoneuron subtype-selective ER stress in disease manifestations of FALS mice. Nat. Neurosci. 12:627-636.
110. Schaefer, A. M., J. R. Sanes, and J. W. Lichtman. 2005. A compensatory subpopulation of motor neurons in a mouse model of amyotrophic lateral sclerosis. J. Comp. Neurol. 490:209-219.
111. Schaefer, M. K., H. Schmalbruch, E. Buhler, C. Lopez, N. Martin, J. L. Guénet, and G. Haase. 2007. Progressive motor neuronopathy: a critical role of the tubulin chaperone TBCE in axonal tubulin routing from the Golgi apparatus. J. Neurosci. 27:8779-8789.
112. Schiffer, D., S. Cordera, P. Cavalla, and A. Migheli. 1996. Reactive astrogliosis of the spinal cord in amyotrophic lateral sclerosis. J. Neurol. Sci. 139(Suppl.):27-33.
113. Schmidt, R. E., C. A. Parvin, and K. G. Green. 2008. Synaptic ultrastructural alterations anticipate the development of neuroaxonal dystrophy in sympathetic ganglia of aged and diabetic mice. J. Neuropathol. Exp. Neurol. 67:1166-1186.
114. Schon, E. A., and S. Przedborski. 2011. Mitochondria: the next (neurode)generation. Neuron 70:1033-1053.
115. Shi, P., Y. Wei, J. Zhang, J. Gal, and H. Zhu. 2010. Mitochondrial dysfunction is a converging point of multiple pathological pathways in amyotrophic lateral sclerosis. J. Alzheimers Dis. 20(Suppl. 2):S311-S324.
116. Siklós, L., J. Engelhardt, Y. Harati, R. G. Smith, F. Joó, and S. H. Appel. 1996. Ultrastructural evidence for altered calcium in motor nerve terminals in amyotrophic lateral sclerosis. Ann. Neurol. 39:203-216.
117. Stieber, A., Y. Chen, S. Wei, Z. Mourelatos, J. Gonatas, K. Okamoto, and N. K. Gonatas. 1998. The fragmented neuronal Golgi apparatus in amyotrophic lateral sclerosis includes the trans-Golgi-network: functional implications. Acta Neuropathol. 95:245-253.
118. Suzuki, M., J. McHaugh, C. Tork, B. Shelley, S. M. Klein, P. Aebischer, et al. 2007. GDNF secreting human neural progenitor cells protect dying motor neurons, but not their projection to muscle, in a rat model of familial ALS. PLoS ONE 8:1-14.
119. Tarabal, O., J. Calderó, C. Casas, R. W. Oppenheim, and J. E. Esquerda. 2005. Protein retention in the endoplasmic reticulum, blockade of programmed cell death and autophagy selectively occur in spinal cord motoneurons after glutamate receptor-mediated injury. Mol. Cell. Neurosci. 29:283-298.
120. Taylor, A., D. Gifondorwa, M. Robinson, J. Strupe, D. Prevette, J. Johnson, et al. 2012. Motoneuron programmed cell death in response to proBDNF. Dev. Neurobiol. 72:699-712. doi: 10.1002/dneu.20964.
121. Tsujihata, M., R. Hazama, T. Yoshimura, A. Satoh, M. Mori, and S. Nagataki. 1984. The motor end-plate fine structure and ultrastructural localization of acetylcholine receptors in amyotrophic lateral sclerosis. Muscle Nerve 7:243-249.
122. Valdez, G., J. C. Tapia, H. Kang, G. D. Clemenson Jr., F. H. Gage, J. W. Lichtman, et al. 2010. Attenuation of age-related changes in mouse neuromuscular synapses by caloric restriction and exercise. Proc. Natl. Acad. Sci. USA 107:14863-14868.
123. Van Harreveld, A., and F. I. Khattab. 1967. Electron microscopy of asphyxiated spinal cords of cats. J. Neuropathol. Exp. Neurol. 26:521-536.
124. Wakabayashi, T. 2002. Megamitochondria formation - physiology and pathology. J. Cell Mol. Med. 6:497-538.
125. Williamson, T. L., and D. W. Cleveland. 1999. Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons. Nat. Neurosci. 2:50-56.
126. Wishart, T. M., S. H. Parson, and T. H. Gillingwater. 2006. Synaptic vulnerability in neurodegenerative disease. J. Neuropathol. Exp. Neurol. 65:733-739.
127. Yates, R. D., and J. C. Yates. 1972. Ultrastructural studies of the effects of various agents on the motor neurons of the spinal cord. Am. J. Anat. 135:345-357.
128. Yoshikawa, M., S. Vinsant, C. M. Mansfield, R. J. Moreno, D. J. Gifondorwa, L. Pace, et al. 2009. Identification of changes in muscle, neuromuscular junctions and spinal cord at early pre-symptomatic stages in the mutant SOD1 mouse model of ALS may provide novel insight for diagnosis and treatment development. Soc. Neurosci. Abstr. 39:5.
129. Zagoraiou, L., T. Akay, J. F. Martin, R. M. Brownstone, T. M. Jessell, and G. B. Miles. 2009. A cluster of cholinergic premotor interneurons modulates mouse locomotor activity. Neuron 64:645-662.
130. Zhong, Z., R. Deane, Z. Ali, M. Parisi, Y. Shapovalov, M. K. O'Banion, et al. 2008. ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration. Nat. Neurosci. 11:420-422.
131. Zhong, Z., H. Ilieva, L. Hallagan, R. Bell, I. Singh, N. Paquette, et al. 2009. Activated protein C therapy slows ALS-like disease in mice by transcriptionally inhibiting SOD1 in motor neurons and microglia cells. J. Clin. Invest. 119:3437-3449.
132. van Zundert, B., M. H. Peuscher, M. Hynynen, A. Chen, R. L. Neve, R. H. Brown Jr., et al. 2008. Neonatal neuronal circuitry shows hyperexcitable disturbance in a mouse model of the adult-onset neurodegenerative disease amyotrophic lateral sclerosis. J. Neurosci. 28:10864-10874.